Frontier Capital Management Co. LLC lessened its holdings in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 13.2% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 747,966 shares of the medical research company’s stock after selling […]
Sandler Capital Management purchased a new stake in Exact Sciences Co. (NASDAQ:EXAS – Free Report) in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 67,181 shares of the medical research company’s stock, valued at approximately $4,556,000. A number of other […]
Rhumbline Advisers grew its position in Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 1.3% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 199,394 shares of the medical research company’s stock after purchasing an additional 2,575 shares during the period. Rhumbline Advisers owned approximately 0.11% […]
StockNews.com started coverage on shares of Exact Sciences (NASDAQ:EXAS – Get Rating) in a research report sent to investors on Thursday morning. The brokerage issued a hold rating on the medical research company’s stock. Several other analysts have also recently issued reports on EXAS. Cowen upped their price target on shares of Exact Sciences from […]
Craig Hallum upgraded shares of Exact Sciences (NASDAQ:EXAS – Get Rating) from a hold rating to a buy rating in a research note issued to investors on Wednesday morning, The Fly reports. They currently have $85.00 target price on the medical research company’s stock, up from their prior target price of $55.00. Other analysts have […]